BioRestorative Therapies (FRA:9OF) Days Sales Outstanding : 144.93 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is BioRestorative Therapies Days Sales Outstanding?

BioRestorative Therapies's average Accounts Receivable for the three months ended in Dec. 2023 was €0.03 Mil. BioRestorative Therapies's Revenue for the three months ended in Dec. 2023 was €0.02 Mil. Hence, BioRestorative Therapies's Days Sales Outstanding for the three months ended in Dec. 2023 was 144.93.

The historical rank and industry rank for BioRestorative Therapies's Days Sales Outstanding or its related term are showing as below:

FRA:9OF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 31.94 Med: 87.28 Max: 501.88
Current: 57.5

During the past 13 years, BioRestorative Therapies's highest Days Sales Outstanding was 501.88. The lowest was 31.94. And the median was 87.28.

FRA:9OF's Days Sales Outstanding is ranked better than
62.7% of 890 companies
in the Biotechnology industry
Industry Median: 72.665 vs FRA:9OF: 57.50

BioRestorative Therapies's Days Sales Outstanding declined from Dec. 2022 (684.38) to Dec. 2023 (144.93).

BioRestorative Therapies Days Sales Outstanding Historical Data

The historical data trend for BioRestorative Therapies's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioRestorative Therapies Days Sales Outstanding Chart

BioRestorative Therapies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

84.23

124.56

80.12

30.69

43.58

BioRestorative Therapies Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															684.38	47.20	28.90	94.40	144.93

Competitive Comparison of BioRestorative Therapies's Days Sales Outstanding

For the Biotechnology subindustry, BioRestorative Therapies's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioRestorative Therapies's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioRestorative Therapies's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where BioRestorative Therapies's Days Sales Outstanding falls into.

BioRestorative Therapies Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

BioRestorative Therapies's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.015	+	0.017)	/	2 )	/	0.134	*	365
=	0.016					/	0.134	*	365
=	43.58

BioRestorative Therapies's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.037	+	0.017)	/	2 )	/	0.017	*	365 / 4
=	0.027					/	0.017	*	365 / 4
=	144.93

BioRestorative Therapies (FRA:9OF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

BioRestorative Therapies Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of BioRestorative Therapies's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

BioRestorative Therapies (FRA:9OF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioRestorative Therapies Inc (FRA:9OF) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

BRTX:USA

Address

40 Marcus Drive, Suite One, Melville, NY, USA, 11747

Website

https://www.biorestorative.com

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

BioRestorative Therapies (FRA:9OF) Headlines

No Headlines